A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia. 2006

Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
Department of Hematology, Hospital Universitario La Fe, Avenida Campanar, 21, 46009 Valencia, Spain.

Acute promyelocytic leukemia (APL) is genetically characterized by a reciprocal translocation between chromosomes 15 and 17, the t(15;17)(q22;q21), which results in the fusion gene PML/RARA. A small proportion of patients with APL have complex or simple variants of this translocation. We report the case of a 31-year-old woman with APL (FAB-M3 classical form) carrying an apparently balanced translocation t(17;20)(q21;q12) masking a t(15;17)(q22;q21) confirmed by fluorescence in situ hybridization (FISH) and molecular studies. The patient was treated with an all-trans-retinoic acid (ATRA) plus anthracycline-based protocol and achieved complete remission, with no recurrence to date. These results illustrate the usefulness of combining cytogenetics, FISH, and reverse transcription-polymerase chain reaction (RT-PCR) methods to evidence the PML/RARA fusion gene in cases with morphologic suspicion of APL with variant or cryptic t(15;17).

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002884 Chromosomes, Human, Pair 15 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 15
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D002890 Chromosomes, Human, Pair 20 A specific pair of GROUP F CHROMOSOMES of the human chromosome classification. Chromosome 20
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid

Related Publications

Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
April 1998, Cancer genetics and cytogenetics,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
January 2013, Medical oncology (Northwood, London, England),
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
January 1988, Leukemia,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
March 2009, Leukemia & lymphoma,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
February 2013, Pathology,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
April 2011, International journal of hematology,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
January 2000, Genes, chromosomes & cancer,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
December 2005, European journal of internal medicine,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
January 1994, Cancer genetics and cytogenetics,
Zaida García-Casado, and José Cervera, and Ana Valencia, and Juan C Pajuelo, and Armando V Mena-Duran, and Eva Barragán, and Pascual Bolufer, and Miguel A Sanz
January 2020, Molecular cytogenetics,
Copied contents to your clipboard!